Literature DB >> 11070355

Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells.

Y Otake1, A L Nolan, U K Walle, T Walle.   

Abstract

Estrogen sulfotransferase (EST) is the sole sulfotransferase expressed in normal human breast epithelial cells and has an important function in determining free estrogen hormone levels in these cells. In the present study we examined the inhibitory effect of the dietary polyphenols quercetin and resveratrol on EST activity, i.e. 17beta-estradiol (E2) sulfation. Both the compounds potently inhibited recombinant human EST in a competitive fashion with K(i) values of about 1 microM. In fact, both polyphenols could serve as substrates for EST. In order to extend the studies to more physiologically relevant conditions, we examined whether inhibition of EST also occurred in the intact cultured human mammary epithelial (HME) cells. The mean baseline EST activity (E2 sulfate formation) in the HME cells was 4.4 pmol/h per mg protein. The IC(50) for resveratrol was very similar to that for recombinant EST, i.e. about 1 microM. Surprisingly, quercetin was 10 times more potent in the HME cells with an IC(50) of about 0.1 microM, a concentration that should be possible to achieve from the normal dietary content of this flavonoid.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070355     DOI: 10.1016/s0960-0760(00)00073-x

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  17 in total

1.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

Review 2.  New targets and inhibitors of mycobacterial sulfur metabolism.

Authors:  Hanumantharao Paritala; Kate S Carroll
Journal:  Infect Disord Drug Targets       Date:  2013-04

Review 3.  Modulation of estrogen synthesis and metabolism by phytoestrogens in vitro and the implications for women's health.

Authors:  Majorie B M van Duursen
Journal:  Toxicol Res (Camb)       Date:  2017-09-08       Impact factor: 3.524

4.  Resveratrol and its methoxy derivatives modulate the expression of estrogen metabolism enzymes in breast epithelial cells by AhR down-regulation.

Authors:  Barbara Licznerska; Hanna Szaefer; Marcin Wierzchowski; Hanna Sobierajska; Wanda Baer-Dubowska
Journal:  Mol Cell Biochem       Date:  2016-11-16       Impact factor: 3.396

5.  Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase II metabolic pathways.

Authors:  Wen Jiang; Ming Hu
Journal:  RSC Adv       Date:  2012-09-21       Impact factor: 3.361

6.  Effects of pterostilbene in brown adipose tissue from obese rats.

Authors:  Leixuri Aguirre; Iñaki Milton-Laskibar; Elizabeth Hijona; Luis Bujanda; Agnes M Rimando; María P Portillo
Journal:  J Physiol Biochem       Date:  2017-02-27       Impact factor: 4.158

7.  Quercetin Induces Dose-Dependent Differential Morphological and Proliferative Changes in Rat Uteri in the Presence and in the Absence of Estrogen.

Authors:  Huma Shahzad; Nelli Giribabu; Muniandy Sekaran; Naguib Salleh
Journal:  J Med Food       Date:  2015-07-02       Impact factor: 2.786

8.  Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases.

Authors:  Anne Caroline S Barbosa; Ye Feng; Chaohui Yu; Min Huang; Wen Xie
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-03-18       Impact factor: 4.481

9.  Celecoxib affects estrogen sulfonation catalyzed by several human hepatic sulfotransferases, but does not stimulate 17-sulfonation in rat liver.

Authors:  Sriram Ambadapadi; Peter L Wang; Sergiu P Palii; Margaret O James
Journal:  J Steroid Biochem Mol Biol       Date:  2017-05-25       Impact factor: 4.292

Review 10.  Drug targets in mycobacterial sulfur metabolism.

Authors:  Devayani P Bhave; Wilson B Muse; Kate S Carroll
Journal:  Infect Disord Drug Targets       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.